Lifestyle interventions in cardiometabolic HFpEF: dietary and exercise modalities
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Lifestyle interventions in cardiometabolic HFpEF: dietary and exercise modalities ; day:16 ; month:9 ; year:2024 ; pages:1-19
Heart failure reviews ; (16.9.2024), 1-19
- Urheber
-
Vacca, Antonio
Wang, Rongling
Nambiar, Natasha
Capone, Federico
Farrelly, Catherine
Mostafa, Ahmed
Sechi, Leonardo A.
Schiattarella, Gabriele G.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10741-024-10439-1
- URN
-
urn:nbn:de:101:1-2411292101337.034090064523
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Vacca, Antonio
- Wang, Rongling
- Nambiar, Natasha
- Capone, Federico
- Farrelly, Catherine
- Mostafa, Ahmed
- Sechi, Leonardo A.
- Schiattarella, Gabriele G.
- SpringerLink (Online service)
Ähnliche Objekte (12)
NASH triggers cardiometabolic HFpEF in aging mice
Inflammation in obesity-related HFpEF: the STEP-HFpEF program
Benefits of peritoneal ultrafiltration in HFpEF and HFrEF patients
Different determinants of exercise capacity in HFpEF compared to HFrEF
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial
Post-discharge changes in nutritional status predict prognosis in patients with acute decompensated HFpEF from the PURSUIT-HFpEF Registry
Epicardial adipose tissue density is a better predictor of cardiometabolic risk in HFpEF patients: a prospective cohort study
HFpEF as systemic disease, insight from a diagnostic prediction model reminiscent of systemic inflammation and organ interaction in HFpEF patients
Impact of different training modalities on high-density lipoprotein function in HFpEF patients : a substudy of the OptimEx trial
Saturated Fatty Acid Blood Levels and Cardiometabolic Phenotype in Patients with HFpEF : A Secondary Analysis of the Aldo-DHF Trial
From Mouse Models to Patients: A Comparative Bioinformatic Analysis of HFpEF and HFrEF
NASH triggers cardiometabolic HFpEF in aging mice
Inflammation in obesity-related HFpEF: the STEP-HFpEF program
Benefits of peritoneal ultrafiltration in HFpEF and HFrEF patients
Different determinants of exercise capacity in HFpEF compared to HFrEF
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial
Post-discharge changes in nutritional status predict prognosis in patients with acute decompensated HFpEF from the PURSUIT-HFpEF Registry
Epicardial adipose tissue density is a better predictor of cardiometabolic risk in HFpEF patients: a prospective cohort study
HFpEF as systemic disease, insight from a diagnostic prediction model reminiscent of systemic inflammation and organ interaction in HFpEF patients
Impact of different training modalities on high-density lipoprotein function in HFpEF patients : a substudy of the OptimEx trial
Saturated Fatty Acid Blood Levels and Cardiometabolic Phenotype in Patients with HFpEF : A Secondary Analysis of the Aldo-DHF Trial
From Mouse Models to Patients: A Comparative Bioinformatic Analysis of HFpEF and HFrEF
NASH triggers cardiometabolic HFpEF in aging mice
Inflammation in obesity-related HFpEF: the STEP-HFpEF program
Benefits of peritoneal ultrafiltration in HFpEF and HFrEF patients
Different determinants of exercise capacity in HFpEF compared to HFrEF
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial
Post-discharge changes in nutritional status predict prognosis in patients with acute decompensated HFpEF from the PURSUIT-HFpEF Registry
Epicardial adipose tissue density is a better predictor of cardiometabolic risk in HFpEF patients: a prospective cohort study
HFpEF as systemic disease, insight from a diagnostic prediction model reminiscent of systemic inflammation and organ interaction in HFpEF patients
Impact of different training modalities on high-density lipoprotein function in HFpEF patients : a substudy of the OptimEx trial
Saturated Fatty Acid Blood Levels and Cardiometabolic Phenotype in Patients with HFpEF : A Secondary Analysis of the Aldo-DHF Trial